These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36706963)

  • 1. Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: Active, prospective national surveillance, January-March 2022, England.
    Hani E; Bertran M; Powell A; Williams H; Birrell P; DeAngelis D; Ramsay ME; Oligbu G; Ladhani SN
    J Infect; 2023 Apr; 86(4):397-398. PubMed ID: 36706963
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
    Bertran M; Amin-Chowdhury Z; Davies HG; Allen H; Clare T; Davison C; Sinnathamby M; Seghezzo G; Kall M; Williams H; Gent N; Ramsay ME; Ladhani SN; Oligbu G
    PLoS Med; 2022 Nov; 19(11):e1004118. PubMed ID: 36346784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
    Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
    Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England.
    Mensah AA; Sinnathamby M; Zaidi A; Coughlan L; Simmons R; Ismail SA; Ramsay ME; Saliba V; Ladhani SN
    J Infect; 2021 Apr; 82(4):67-74. PubMed ID: 33639175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 in children: analysis of the first pandemic peak in England.
    Ladhani SN; Amin-Chowdhury Z; Davies HG; Aiano F; Hayden I; Lacy J; Sinnathamby M; de Lusignan S; Demirjian A; Whittaker H; Andrews N; Zambon M; Hopkins S; Ramsay ME
    Arch Dis Child; 2020 Dec; 105(12):1180-1185. PubMed ID: 32796006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.
    Brooks-Pollock E; Northstone K; Pellis L; Scarabel F; Thomas A; Nixon E; Matthews DA; Bowyer V; Garcia MP; Steves CJ; Timpson NJ; Danon L
    BMC Med; 2023 Jan; 21(1):25. PubMed ID: 36658548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England.
    Elliott P; Eales O; Bodinier B; Tang D; Wang H; Jonnerby J; Haw D; Elliott J; Whitaker M; Walters CE; Atchison C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Ward H; Darzi A; Cooke GS; Chadeau-Hyam M; Donnelly CA
    Nat Commun; 2022 Aug; 13(1):4500. PubMed ID: 35922409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).
    Pazukhina E; Rumyantsev M; Baimukhambetova D; Bondarenko E; Markina N; El-Taravi Y; Petrova P; Ezhova A; Andreeva M; Iakovleva E; Bobkova P; Pikuza M; Trefilova A; Abdeeva E; Galiautdinova A; Filippova Y; Bairashevskaia A; Zolotarev A; Bulanov N; DunnGalvin A; Chernyavskaya A; Kondrikova E; Kolotilina A; Gadetskaya S; Ivanova YV; Turina I; Eremeeva A; Fedorova LA; Comberiati P; Peroni DG; Nekliudov N; Genuneit J; Reyes LF; Brackel CLH; Mazankova L; Miroshina A; Samitova E; Borzakova S; Carson G; Sigfrid L; Scott JT; McFarland S; Greenhawt M; Buonsenso D; Semple MG; Warner JO; Olliaro P; Osmanov IM; Korsunskiy AA; Munblit D;
    BMC Med; 2024 Feb; 22(1):48. PubMed ID: 38302974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study.
    Meredith LW; Hamilton WL; Warne B; Houldcroft CJ; Hosmillo M; Jahun AS; Curran MD; Parmar S; Caller LG; Caddy SL; Khokhar FA; Yakovleva A; Hall G; Feltwell T; Forrest S; Sridhar S; Weekes MP; Baker S; Brown N; Moore E; Popay A; Roddick I; Reacher M; Gouliouris T; Peacock SJ; Dougan G; Török ME; Goodfellow I
    Lancet Infect Dis; 2020 Nov; 20(11):1263-1272. PubMed ID: 32679081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.
    Hippisley-Cox J; Khunti K; Sheikh A; Nguyen-Van-Tam JS; Coupland CAC
    BMJ; 2023 Jun; 381():e072976. PubMed ID: 37343968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.
    Ismail SA; Saliba V; Lopez Bernal J; Ramsay ME; Ladhani SN
    Lancet Infect Dis; 2021 Mar; 21(3):344-353. PubMed ID: 33306981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
    Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
    Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study.
    Krutikov M; Stirrup O; Nacer-Laidi H; Azmi B; Fuller C; Tut G; Palmer T; Shrotri M; Irwin-Singer A; Baynton V; Hayward A; Moss P; Copas A; Shallcross L;
    Lancet Healthy Longev; 2022 May; 3(5):e347-e355. PubMed ID: 35531432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study.
    Callaghan CJ; Curtis RMK; Mumford L; Whitaker H; Pettigrew G; Gardiner D; Marson L; Thorburn D; White S; Parmar J; Ushiro-Lumb I; Manas D; Ravanan R;
    Transplantation; 2023 May; 107(5):1124-1135. PubMed ID: 36727724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.
    Laxminarayan R; B CM; G VT; Arjun Kumar KV; Wahl B; Lewnard JA
    Lancet Infect Dis; 2021 Dec; 21(12):1665-1676. PubMed ID: 34399090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England.
    Ladhani SN; Ireland G; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Aiano F; Amin-Chowdhury Z; Kall M; Borrow R; Linley E; Zambon M; Poh J; Warrener L; Lackenby A; Ellis J; Amirthalingam G; Brown KE; Ramsay ME
    J Infect; 2021 Nov; 83(5):573-580. PubMed ID: 34400220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.